Results of a multivariate Cox regression analysis of the Singhal study showed that T-AML, high revised International Prognostic Scoring System cytogenetic category, TP53 variant, and NRAS variant were independent aggressive factors, however, treatment with disease-modifying therapy resulted in better OS. The gene discussed is NRAS; the disease is acute myeloid leukemia.